Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-3093Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2024-05-28 / Ann Transl Med 2024 Aug;12(4):77The future of cancer vaccines against colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-284Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
/in Dendritic Cells, International Publications, NSCLC /von 2024-04-09 / Cell Rep Med 2024 Apr;:101516Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2024-04-09 / Med Oncol 2024 Apr;41(5):112An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2024-03-16 / Inflammation 2024 Mar;Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2024-02-20 / Front Immunol 2024;15:1368103Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report
/in Dendritic Cells, International Publications, NSCLC /von 2024-02-10 / J Med Case Rep 2024 Feb;18(1):88Glioblastoma vaccines: past, present, and opportunities
/in Dendritic Cells, Glioblastoma, International Publications /von 2024-01-05 / EBioMedicine 2024 Jan;100:104963
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de